Treace Announces First Surgical Cases with the Tailorplasty™ MIS Tailor’s Bunion Correction System
Key Highlights
- ➤First Tailorplasty™ cases completed, extending Treace’s bunion correction platform to bunionettes
- ➤Tailorplasty™ targets painful fifth-metatarsal deformities affecting approximately 5-10% of adults
- ➤Tailorplasty™ offers instrument-guided MIS correction through a less-than-1cm incision
- ➤Tailorplasty™ represents an estimated $300M TAM expansion opportunity for Treace
- ➤Commercialization anticipated in the first quarter of 2027
Expert Statements
Jonathan Kaplan, MD; Surgeon design team member for the Tailorplasty™ System, Prisma Health / University of South Carolina School of Medicine
“Tailor’s bunions are a condition I commonly treat in my practice, both in my bunion patients and as standalone deformities. Tailor’s bunion correction has traditionally required either a large open incision or a challenging freehand MIS technique, where achieving proper alignment of the osteotomy, and secure fixation, can be unpredictable and lead to inconsistent results. Our goal with the Tailorplasty™ System was to help surgeons confidently achieve a quick, controlled, and accurate correction of this deformity through a MIS approach and help patients return to their active lives quickly.”
John T. Treace, CEO and Chairman of Treace
“Our initial Tailorplasty™ cases mark another important step in the continued expansion of our market-leading 3D bunion correction portfolio”
John T. Treace, CEO and Chairman of Treace
“As a common deformity affecting an estimated 5-10% of adults in the US, we estimate the Tailorplasty™ System represents an underserved $300M TAM expansion opportunity for our business.”
John T. Treace, CEO and Chairman of Treace
“Consistent with our other best-in-class bunion systems, Tailorplasty™ delivers a new solution aimed to transform a challenging freehand surgery to one with instrumented control and reproducibility.”
John T. Treace, CEO and Chairman of Treace
“The addition of the Tailorplasty™ System further advances Treace’s objective to become a more comprehensive foot and ankle technology partner for our surgeon customers.”
PONTE VEDRA, Fla., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (Nasdaq: TMCI), a medical technology company with the goal of being the recognized leader in the surgical treatment of bunions and other foot & ankle conditions, today announced the successful completion of the first cases utilizing its Tailorplasty™ MIS Tailor’s Bunion Correction System.
The Tailorplasty™ procedure extends Treace's instrumented bunion correction platform to tailor's bunions, or "bunionettes” which are painful deformities of the fifth metatarsal estimated to affect approximately 5-10% of the adult population.
Get started
Create a free account to read the full story.